Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model-Reference-Cited by-同舟云学术

Nanoparticle Formulation of Moxifloxacin and Intramuscular Route of Delivery Improve Antibiotic Pharmacokinetics and Treatment of Pneumonic Tularemia in a Mouse Model

Published:2018-11-27 Issue:2 Volume:5 Page:281-291
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Clemens Daniel L.¹^ORCID,Lee Bai-Yu¹,Plamthottam Sheba²,Tullius Michael V.¹,Wang Ruining²,Yu Chia-Jung²,Li Zilu²,Dillon Barbara Jane¹,Zink Jeffrey I.²³^ORCID,Horwitz Marcus A.¹

Affiliation:

1. Division of Infectious Diseases, Department of Medicine, University of California, CHS 37-121, 10833 Le Conte Avenue, Los Angeles, California 90095-1688, United States

2. Department of Chemistry and Biochemistry, University of California, 3013 Young Drive East, Los Angeles, California 90095-1569, United States

3. California NanoSystems Institute, University of California, Los Angeles, California 90095-8352, United States

Funder

Defense Threat Reduction Agency

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.8b00268

Reference41 articles.

1. Mesoporous silica nanoparticles in biomedical applications